Home > Result Summaries: Compounds > orlistat

Result Summaries: orlistat

GSK Study ID	Phase	Title	Summary (Download)
111963	phase 1	A Longitudinal MRI Study of Changes in Regional Body Composition During Orlistat (60mg)-Assisted Dieting (1 citation(s))
114237	phase 4	Meta-analysis of orlistat laboratory data from placebo-controlled clinical trials (0 citation(s))
W2650782	phase 1	A pharmacokinetic study of two oral formulations of orlistat (0 citation(s))
W2651062	phase 1	A Study to Assess the Pharmacodynamic Equivalence of Two Orlistat Dosage Forms (0 citation(s))
W3600586	phase 4	The effects of weight reduction with orlistat vs. placebo on changes in body composition (1 citation(s))
W3680604	phase 1	A study to assess the pharmacologic equivalence of two orlistat dosage forms (0 citation(s))
W3730613	phase 1	A Dose-Ranging Study of a Tablet Formulation of Orlistat (0 citation(s))
W5350856	n\a	Survey on the pharmacy follow up of Alli purchasers (0 citation(s))